TY  - JOUR
AU  - van Gelder, M
AU  - de Wreede, L C
AU  - Bornhäuser, M
AU  - Niederwieser, D
AU  - Karas, M
AU  - Anderson, N S
AU  - Gramatzki, M
AU  - Dreger, P
AU  - Michallet, M
AU  - Petersen, E
AU  - Bunjes, D
AU  - Potter, M
AU  - Beelen, D
AU  - Cornelissen, J J
AU  - Yakoub-Agha, I
AU  - Russell, N H
AU  - Finke, J
AU  - Schoemans, H
AU  - Vitek, A
AU  - Urbano-Ispízua, Á
AU  - Blaise, D
AU  - Volin, L
AU  - Chevallier, P
AU  - Caballero, D
AU  - Putter, H
AU  - van Biezen, A
AU  - Henseler, A
AU  - Schönland, S
AU  - Kröger, N
AU  - Schetelig, J
PY  - 2016
DO  - 10.1038/bmt.2016.282
UR  - https://hdl.handle.net/10668/25107
T2  - Bone marrow transplantation
AB  - Even with the availability of targeted drugs, allogeneic hematopoietic cell transplantation (allo-HCT) is the only therapy with curative potential for patients with CLL. Cure can be assessed by comparing long-term survival of patients to the matched...
LA  - en
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Allografts
KW  - Child
KW  - Disease-Free Survival
KW  - Europe
KW  - Female
KW  - Follow-Up Studies
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - Male
KW  - Middle Aged
KW  - Societies, Medical
KW  - Survival Rate
KW  - Time Factors
TI  - Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.
TY  - research article
VL  - 52
ER  -